Logo image of 1SUS.MI

SENTINELONE INC -CLASS A (1SUS.MI) Stock Fundamental Analysis

Europe - BIT:1SUS - US81730H1095 - Common Stock

14.25 EUR
-0.75 (-5%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

4

Overall 1SUS gets a fundamental rating of 4 out of 10. We evaluated 1SUS against 110 industry peers in the Software industry. 1SUS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 1SUS shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year 1SUS was profitable.
1SUS had a positive operating cash flow in the past year.
1SUS had negative earnings in each of the past 5 years.
1SUS had negative operating cash flow in 4 of the past 5 years.
1SUS.MI Yearly Net Income VS EBIT VS OCF VS FCF1SUS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

The Return On Assets of 1SUS (-18.27%) is worse than 83.64% of its industry peers.
1SUS has a Return On Equity of -28.48%. This is in the lower half of the industry: 1SUS underperforms 75.45% of its industry peers.
Industry RankSector Rank
ROA -18.27%
ROE -28.48%
ROIC N/A
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
1SUS.MI Yearly ROA, ROE, ROIC1SUS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100 200 300

1.3 Margins

Looking at the Gross Margin, with a value of 74.95%, 1SUS is in line with its industry, outperforming 59.09% of the companies in the same industry.
In the last couple of years the Gross Margin of 1SUS has grown nicely.
The Profit Margin and Operating Margin are not available for 1SUS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
1SUS.MI Yearly Profit, Operating, Gross Margins1SUS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

6

2. Health

2.1 Basic Checks

1SUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1SUS has been increased compared to 1 year ago.
1SUS has more shares outstanding than it did 5 years ago.
1SUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1SUS.MI Yearly Shares Outstanding1SUS.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M
1SUS.MI Yearly Total Debt VS Total Assets1SUS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

1SUS has an Altman-Z score of 2.99. This is not the best score and indicates that 1SUS is in the grey zone with still only limited risk for bankruptcy at the moment.
1SUS's Altman-Z score of 2.99 is in line compared to the rest of the industry. 1SUS outperforms 45.45% of its industry peers.
1SUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.99
ROIC/WACCN/A
WACC11.02%
1SUS.MI Yearly LT Debt VS Equity VS FCF1SUS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

1SUS has a Current Ratio of 1.83. This is a normal value and indicates that 1SUS is financially healthy and should not expect problems in meeting its short term obligations.
1SUS has a better Current ratio (1.83) than 65.45% of its industry peers.
1SUS has a Quick Ratio of 1.83. This is a normal value and indicates that 1SUS is financially healthy and should not expect problems in meeting its short term obligations.
1SUS has a better Quick ratio (1.83) than 68.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.83
1SUS.MI Yearly Current Assets VS Current Liabilites1SUS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

8

3. Growth

3.1 Past

1SUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 350.00%, which is quite impressive.
Looking at the last year, 1SUS shows a very strong growth in Revenue. The Revenue has grown by 25.39%.
Measured over the past years, 1SUS shows a very strong growth in Revenue. The Revenue has been growing by 77.59% on average per year.
EPS 1Y (TTM)350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)25.39%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%21.74%

3.2 Future

The Earnings Per Share is expected to grow by 84.57% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.16% on average over the next years. This is a very strong growth
EPS Next Y281.83%
EPS Next 2Y157.72%
EPS Next 3Y111.31%
EPS Next 5Y84.57%
Revenue Next Year22.3%
Revenue Next 2Y21.43%
Revenue Next 3Y20.43%
Revenue Next 5Y22.16%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1SUS.MI Yearly Revenue VS Estimates1SUS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
1SUS.MI Yearly EPS VS Estimates1SUS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 2

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 158.33 indicates a quite expensive valuation of 1SUS.
1SUS's Price/Earnings is on the same level as the industry average.
1SUS is valuated expensively when we compare the Price/Earnings ratio to 27.77, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 49.81, 1SUS can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1SUS is on the same level as its industry peers.
1SUS is valuated expensively when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 158.33
Fwd PE 49.81
1SUS.MI Price Earnings VS Forward Price Earnings1SUS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as 1SUS.
Industry RankSector Rank
P/FCF 333.93
EV/EBITDA N/A
1SUS.MI Per share data1SUS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

1SUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1SUS's earnings are expected to grow with 111.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y157.72%
EPS Next 3Y111.31%

0

5. Dividend

5.1 Amount

No dividends for 1SUS!.
Industry RankSector Rank
Dividend Yield N/A

SENTINELONE INC -CLASS A

BIT:1SUS (10/17/2025, 7:00:00 PM)

14.25

-0.75 (-5%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-28 2025-08-28/amc
Earnings (Next)12-02 2025-12-02/amc
Inst Owners82.27%
Inst Owner ChangeN/A
Ins Owners0.53%
Ins Owner ChangeN/A
Market Cap4.78B
Revenue(TTM)907.38M
Net Income(TTM)-429364000
Analysts78.18
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.04%
Min EPS beat(2)23.01%
Max EPS beat(2)37.07%
EPS beat(4)3
Avg EPS beat(4)33.72%
Min EPS beat(4)-100%
Max EPS beat(4)174.81%
EPS beat(8)7
Avg EPS beat(8)85.06%
EPS beat(12)11
Avg EPS beat(12)65.32%
EPS beat(16)15
Avg EPS beat(16)53.02%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-1.95%
Max Revenue beat(2)-1.67%
Revenue beat(4)0
Avg Revenue beat(4)-1.42%
Min Revenue beat(4)-1.95%
Max Revenue beat(4)-0.52%
Revenue beat(8)3
Avg Revenue beat(8)-0.28%
Revenue beat(12)5
Avg Revenue beat(12)-0.13%
Revenue beat(16)9
Avg Revenue beat(16)1.44%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-7.57%
EPS NQ rev (3m)-6.08%
EPS NY rev (1m)-4.82%
EPS NY rev (3m)0.2%
Revenue NQ rev (1m)1.26%
Revenue NQ rev (3m)1.21%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)-0.2%
Valuation
Industry RankSector Rank
PE 158.33
Fwd PE 49.81
P/S 6.11
P/FCF 333.93
P/OCF 136.35
P/B 3.68
P/tB 7.07
EV/EBITDA N/A
EPS(TTM)0.09
EY0.63%
EPS(NY)0.29
Fwd EY2.01%
FCF(TTM)0.04
FCFY0.3%
OCF(TTM)0.1
OCFY0.73%
SpS2.33
BVpS3.88
TBVpS2.02
PEG (NY)0.56
PEG (5Y)N/A
Graham Number2.8
Profitability
Industry RankSector Rank
ROA -18.27%
ROE -28.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.95%
FCFM 1.83%
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 53.73%
Cap/Sales 2.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.83
Altman-Z 2.99
F-Score6
WACC11.02%
ROIC/WACCN/A
Cap/Depr(3y)58.32%
Cap/Depr(5y)105.17%
Cap/Sales(3y)3.59%
Cap/Sales(5y)4.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y281.83%
EPS Next 2Y157.72%
EPS Next 3Y111.31%
EPS Next 5Y84.57%
Revenue 1Y (TTM)25.39%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%21.74%
Revenue Next Year22.3%
Revenue Next 2Y21.43%
Revenue Next 3Y20.43%
Revenue Next 5Y22.16%
EBIT growth 1Y-2.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year315.2%
EBIT Next 3Y92.41%
EBIT Next 5YN/A
FCF growth 1Y112.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y133.39%
OCF growth 3YN/A
OCF growth 5YN/A